Bromide
CAS 10035-10-6
Bromide (CAS 10035-10-6) is a pharmaceutical compound with 1 bioactivity target and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Ki | 49850 nM | 2 | - |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| HYDROBROMIC ACID | 1426869 | SU | MTHSPL |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Bromide used for in pharmaceutical contexts?
Bromide (CAS 10035-10-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Bromide?
Bromide has 0 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Intestinal operation, Middle insomnia, Multiple-drug resistance, Off label use, Physical assault. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Bromide also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Hydrobromic Acid with EU status "prohibited".
What clinical phase is Bromide in?
No phase 1-4 clinical development badge is rendered for Bromide because the matched compound identifier rows do not contain a max-phase value.